http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007511582-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2004-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007511582-A |
| titleOfInvention | Pharmaceutical compositions for these treatments in patients with renal failure, kidney disease or disorder, especially in diabetic patients |
| abstract | The present invention comprises an oxo group at the α-position relative to nitrogen and substituted at the 3-position by a 1- (carboxyalkyl) cyclopentylcarbonylamino group in large mammals and particularly humans, preferably diabetic human patients. Suitable for novel use of benzazepine-N-acetic acid derivatives and / or their salts and biologically labile esters and / or their physiologically acceptable solvates, preparation of pharmaceutical compositions and novel treatments Regarding products. The present invention relates in particular to the treatment and / or prevention of renal failure, renal disease or disorder in patients with renal failure, renal disease or disorder, preferably renal disease, but in a broad sense further in addition to patients with syndrome X or in particular addition It relates to the treatment and / or prevention in patients with renal failure, renal disease and / or renal disorders with high blood pressure, obesity, hyperglycemia and / or metabolic disorders. |
| priorityDate | 2003-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 149.